EMEA Region
The Eisai EMEA (Europe, Middle East, Africa) region includes many markets including Australia, Austria, Belgium, the Czech Republic/Slovakia, France, Germany, Luxembourg, the Netherlands, New Zealand the Nordics, Portugal, Russia, Spain and the UK/Ireland. In regions where Eisai EMEA does not have an affiliate, we have entered into partnerships to help relevant patients in these regions access our medicines. Please click on the images below for contact details.
Eisai in the UK
Eisai is very proud to include drug discovery and development research as well as manufacturing to our presence in the UK. Our continued commitment in the UK is demonstrated through an open innovation drug discovery strategy, strategic partnership initiatives and an academic-industrial alliance. Our manufacturing facility processes materials sourced from around the globe, making life saving medicines for world-wide distribution. At our site in Hatfield, Eisai produces nine products in twenty three different strengths and formulations, with the vast majority of the factory output destined for export.
human health care
Our work at Eisai prioritises patients and their families, through our focus to continually improve the benefits that health care can provide.
We call this human health care, (hhc)
FIND OUT MORE
